Drawing for VIVARTEX

USPTO serial 79078117

VIVARTEX

Reviewed by CopyMark Law Group

Reg. 3885616Status 404
Filing date
Status date
Registration date
Dec 7, 2010
Examiner
SEVERSON, KAREN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VIVARTEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical products and substances for the treatment of blood or bleeding disorders; immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapySECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 26, 2015DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Feb 26, 2015DETHDEATH OF INTERNATIONAL REGISTRATION
Apr 8, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Feb 10, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED
Apr 6, 2011FICSFINAL DISPOSITION NOTICE SENT TO IB
Apr 6, 2011FIMPFINAL DISPOSITION PROCESSED
Mar 7, 2011FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 7, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 21, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 1, 2010NPUBNOTICE OF PUBLICATION
Aug 18, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 18, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 17, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 17, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 17, 2010ALIEASSIGNED TO LIE
Aug 2, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 9, 2010RFNTREFUSAL PROCESSED BY IB
Mar 17, 2010RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 17, 2010RFRRREFUSAL PROCESSED BY MPU
Mar 17, 2010RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 16, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 15, 2010DOCKASSIGNED TO EXAMINER
Feb 23, 2010MAFRAPPLICATION FILING RECEIPT MAILED
Feb 17, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2010REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance